Skip to main content
Clinical Trials/NCT05169736
NCT05169736
Recruiting
Not Applicable

Internet-based Cognitive Behavioural Therapy for Mental Health Problems Related to the Climate Crisis

Linkoeping University1 site in 1 country120 target enrollmentFebruary 7, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depression and Quality of Life
Sponsor
Linkoeping University
Enrollment
120
Locations
1
Primary Endpoint
Change in Becks Depression Inventory-II
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The study seeks to investigate the effects of a guided internet-based cognitive behavioral therapy (ICBT) programme on adult mental health problems related to the climate crisis. ICBT will be compared to a wait-list control group.

Participants will be recruited in Sweden with a nationwide recruitment.

Detailed Description

The study is set up as a randomized controlled trial. Quality of life, depressive symptoms, anxiety, sleep problems and traumatic stress will be measured. Given uncertainties regarding the psychological effects connected to the climate crisis, a transproblematic tailored treatment approach will be used that has been tested in several previous trials. However, the present program has been adapted for the target population of people who are affected directly or indirectly by the societal and individual consequences of the climate crisis.

Registry
clinicaltrials.gov
Start Date
February 7, 2022
End Date
June 1, 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Linkoeping University
Responsible Party
Principal Investigator
Principal Investigator

Gerhard Andersson

Professor

Linkoeping University

Eligibility Criteria

Inclusion Criteria

  • Experience mental health problems that are caused or exacerbated by the climate crisis and/or its consequences 18 years or older. Adequate ability to understand and speak Swedish. Access to the internet and a smartphone/computer.

Exclusion Criteria

  • Other ongoing psychological treatment or counselling that interfere with trial treatment.
  • Recent (within the past 3 months) changes in the dose of psychotropic medication.
  • Any severe psychiatric or somatic conditions that would interfere with trial treatment

Outcomes

Primary Outcomes

Change in Becks Depression Inventory-II

Time Frame: Baseline, 8 weeks and follow-up at 12 months after treatment termination

Measure of depressive symptoms. Possible range for the total sum: 0 to 63 (created by summing up the score from each item) with a higher score indicating a higher level of depressive symptoms. Clinical ranges for minimal, mild, moderate and severe major depressive disorder are considered to be 0-13, 13-19, 20-28, and 29-63 points.

Change in Perceived Stress Scale

Time Frame: Baseline, 8 weeks and follow-up at 12 months after treatment termination.

It is a measure of the degree to which situations in one's life are appraised as stressful. It contains 10 items that are scored on a range between 0 (never) to 4 (very often). The total score can range from 0-56 and a higher score reflects higher levels of perceived stress.

Change in Generalised Anxiety Disorder 7-item scale

Time Frame: Baseline, 8 weeks and follow-up at 12 months after treatment termination.

Seven item measure of generalized anxiety disorder. Sum score range from 0 to 21, with higher scores indicating more generalized anxiety. Cut-offs for interpretation: 0-5 minimal anxiety, 6-9 mild anxiety, 10-14 moderate anxiety, and 15-21 severe anxiety.

Secondary Outcomes

  • Change in Alcohol Use Disorder Identification Test(Baseline, 8 weeks and follow-up at 12 months after treatment termination.)
  • Change in Brunnsviken Brief Quality of Life Scale(Baseline, 8 weeks and follow-up at 12 months after treatment termination)
  • Change in Insomnia Severity Index(Baseline, 8 weeks and follow-up at 12 months after treatment termination.)
  • Change in Patient Health Questionnaire(Baseline, 8 weeks and follow-up at 12 months after treatment termination.)
  • Change in ClimateCope Index (CCI)(Baseline, 8 weeks and follow-up at 12 months after treatment termination)

Study Sites (1)

Loading locations...

Similar Trials